A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, China
Preprint
- 20 March 2020
- preprint
- Published by Cold Spring Harbor Laboratory in medRxiv
Abstract
Background: Due to no reliable risk stratification tool for severe corona virus disease 2019 (COVID-19) patients at admission, we aimed to construct an effective model for early identifying cases at high risk of progression to severe COVID-19.Methods: In this retrospective three-centers study, 372 non-severe COVID-19 patients during hospitalization were followed for more than 15 days after admission. Patients who deteriorated to severe or critical COVID-19 and patients who kept non-severe state were assigned to the severe and non-severe group, respectively. Based on baseline data of the two groups, we constructed a risk prediction nomogram for severe COVID-19 and evaluate its performance.Results: The train cohort consisted of 189 patients, while the two independent validation cohorts consisted of 165 and 18 patients. Among all cases, 72 (19.35%) patients developed severe COVID-19. We found that old age, and higher serum lactate dehydrogenase, C-reactive protein, the coefficient of variation of red blood cell distribution width, blood urea nitrogen, direct bilirubin, lower albumin, are associated with severe COVID-19. We generated the nomogram for early identifying severe COVID-19 in the train cohort (AUC 0.912 [95% CI 0.846-0.978], sensitivity 85.71%, specificity 87.58%); in validation cohort (0.853 [0.790-0.916], 77.5%, 78.4%). The calibration curve for probability of severe COVID-19 showed optimal agreement between prediction by nomogram and actual observation. Decision curve and clinical impact curve analysis indicated that nomogram conferred high clinical net benefit.Conclusion: Our nomogram could help clinicians to early identify patients who will exacerbate to severe COVID-19, which will enable better centralized management and early treatment of severe patients.Summary: Older age; higher LDH, CRP, RDW, DBIL, BUN; lower ALB on admission correlated with higher odds of severe COVID-19. An effective prognostic nomogram composed of 7 features could allow early identification of patients at risk of exacerbation to severe COVID-19.Keywords
All Related Versions
- Published version: Clinical Infectious Diseases, 71 (15), 833.
This publication has 17 references indexed in Scilit:
- Relation between Red Cell Distribution Width and Mortality in Critically Ill Patients with Acute Respiratory Distress SyndromeBioMed Research International, 2019
- Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanomaClinical and Experimental Immunology, 2019
- Red cell distribution width predicts out of hospital outcomes in critically ill emergency general surgery patientsTrauma Surgery & Acute Care Open, 2018
- Red blood cells are dynamic reservoirs of cytokinesScientific Reports, 2018
- Red cell distribution width (RDW) as a biomarker for respiratory failure in a pediatric ICUJournal of Inflammation, 2017
- The prognostic value of systemic inflammatory factors in patient with metastatic gastric cancer.Journal of Clinical Oncology, 2017
- RBC Distribution Width: Biomarker for Red Cell Dysfunction and Critical Illness Outcome?*Pediatric Critical Care Medicine, 2017
- Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impactLung India, 2015
- Broadening of the red blood cell distribution width is associated with increased severity of illness in patients with sepsisInternational Journal of Critical Illness and Injury Science, 2014
- Red cell distribution width and all-cause mortality in critically ill patients*Critical Care Medicine, 2011